期刊论文详细信息
BMC Public Health
Can informal social distancing interventions minimize demand for antiviral treatment during a severe pandemic?
Amy L Greer1 
[1]Professional Guidelines and Public Health Practice Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON, Canada
关键词: Social distancing;    Simulation;    Pandemic;    Mathematical model;    Influenza;    Behaviour change;    Antivirals;   
Others  :  1162013
DOI  :  10.1186/1471-2458-13-669
 received in 2013-01-07, accepted in 2013-07-11,  发布年份 2013
PDF
【 摘 要 】

Background

In the case of a pandemic, individuals may alter their behaviour. A dynamic model incorporating social distancing can provide a mechanism to consider complex scenarios to support decisions regarding antiviral stockpile size while considering uncertainty around behavioural interventions. We have examined the impact of social distancing measures on the demand for limited healthcare resources such as antiviral drugs from a central stockpile during a severe pandemic.

Methods

We used an existing age-structured model for pandemic influenza in Canada and biologically plausible scenarios for severe influenza transmission within the population. We incorporated data from published reports regarding stated intentions to change behaviour during a pandemic as well as the magnitude and duration of time that individuals expected to maintain the behavioural change. We ran simulations for all combinations of parameter values to identify the projected antiviral requirements in each scenario.

Results

With 12 weeks of distancing, the effect is relatively small for the lowest R0 of 1.6 with a projected stockpile to treat 25.6% being required (IQR = 21.7 – 28.7%) unless the proportion of people involved (81%) and magnitude of the behaviour change is large (69% reduction in contacts). If 24 weeks of distancing occurs, with only a low to moderate reduction in contacts (38% or less), it is not possible to bring treatment requirements below 20% regardless of what proportion of the population engages in distancing measures when transmissibility is high (R0 = 2.0; stockpile size = 31%, IQR = 29.2 – 33.5%).

Conclusions

Our results demonstrate that the magnitude and duration of social distancing behaviours during a severe pandemic have an impact on the need for antiviral drugs. However, significant investments over a long period of time (>16 weeks) are required to decrease the need for antiviral treatment to below 10% of the total population for a highly transmissible viral strain (R0 > 1.8). Encouraging individuals to adopt behaviours that decrease their daily contact rate can help to control the spread of the virus until a vaccine becomes available however; relying on these measures to justify stockpiling fewer courses of treatment will not be sufficient in the case of a severe pandemic.

【 授权许可】

   
2013 Greer; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150413050803270.pdf 773KB PDF download
Figure 3. 43KB Image download
Figure 2. 46KB Image download
Figure 1. 44KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】
  • [1]Bults M, Beaujean D, de Zwart O, Kok G, van Empelen P, van Steenbergen JE, Richardus JH, Voeten H: Perceived risk, anxiety, and behavioural responses of the general public during the early phase of the Influenza A (H1N1) pandemic in the Netherlands: results of three consecutive online surveys. BMC Publ Health 2011, 11:2. BioMed Central Full Text
  • [2]Ibuka Y, Chapman GB, Meyers LA, Li M, Galvani AP: The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza. BMC Infect Dis 2010, 10:296. BioMed Central Full Text
  • [3]Brauer F: A simple model for behaviour change in epidemics. BMC Publ Health 2011, 11(1):S3. BioMed Central Full Text
  • [4]Brown ST, Tai JHY, Bailey RR, Cooley PC, Wheaton WD, Potter MA, Voorhees RE, LeJeune M, Grefenstette JJ, Burke DS, McGlone SM, Lee BY: Would school closure for the, H1N1 influenza epidemic have been worth the cost?: a computational simulation of Pennsylvania. BMC Publ Health 2009, 2011:11.
  • [5]Hens N, Ayele GM, Goeyvaerts N, Aerts M, Mossong J, Edmunds JW, Beutels P: Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries. BMC Infect Dis 2009, 9:187. BioMed Central Full Text
  • [6]House T, Baguelin M, Van Hoek AJ, White PJ, Sadique Z, Eames K, Read JM, Hens N, Melegaro A, Edmunds WJ, Keeling MJ: Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic. Proceedings of the Royal Society B-Biological Sciences 2011, 278(1719):2753-2760.
  • [7]Milne GJ, Kelso JK, Kelly HA, Huband ST, McVernon J: A Small Community Model for the Transmission of Infectious Diseases: Comparison of School Closure as an Intervention in Individual-Based Models of an Influenza Pandemic. PLoS One 2008, 3:12.
  • [8]Vynnycky E, Edmunds WJ: Analyses of the 1957 (Asian) influenza pandemic in the United Kingdom and the impact of school closures. Epidemiol Infect 2008, 136(2):166-179.
  • [9]Halder N, Kelso JK, Milne GJ: Analysis of the effectiveness of interventions used during the 2009 A/H1N1 influenza pandemic. BMC Publ Health 2010, 10:168. BioMed Central Full Text
  • [10]Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, Burke DS: Strategies for mitigating an influenza pandemic. Nature 2006, 442(7101):448-452.
  • [11]Kelso JK, Milne GJ, Kelly H: Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza. BMC Publ Health 2009, 9:117. BioMed Central Full Text
  • [12]Mao L: Evaluating the Combined Effectiveness of Influenza Control Strategies and Human Preventive Behavior. PLoS One 2011, 6:10.
  • [13]Caley P, Philp DJ, McCracken K: Quantifying social distancing arising from pandemic influenza. J R Soc Interface 2008, 5(23):631-639.
  • [14]Fenichel EP, Castillo-Chavez C, Ceddia MG, Chowell G, Parra PAG, Hickling GJ, Holloway G, Horan R, Morin B, Perrings C, Springborn M, Velazquez L, Villalobos C: Adaptive human behavior in epidemiological models. Proc Natl Acad Sci USA 2011, 108(15):6306-6311.
  • [15]Maharaj S, Kleczkowski A: Controlling epidemic spread by social distancing: Do it well or not at all. BMC Publ Health 2012, 12:679. BioMed Central Full Text
  • [16]Perra N, Balcan D, Goncalves B, Vespignani A: Towards a Characterization of Behavior-Disease Models. PLoS One 2011, 6:8.
  • [17]Poletti P, Ajelli M, Merler S: Risk perception and effectiveness of uncoordinated behavioral responses in an emerging epidemic. Math Biosci 2012, 238(2):80-89.
  • [18]Poletti P, Caprile B, Ajelli M, Pugliese A, Merler S: Spontaneous behavioural changes in response to epidemics. J Theor Biol 2009, 260(1):31-40.
  • [19]The Canadian Pandemic Influenza Plan for the Health Sector: Edited by Public Health Agency of Canada. Ottawa, ON: Government of Canada; 2006.
  • [20]Dimitrov NB, Goll S, Hupert N, Pourbohloul B, Meyers LA: Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic influenza. PLoS One 2011, 6(1):e16094-e16094.
  • [21]McVernon J, McCaw JM, Nolan TM: Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response. Aust N Z J Public Health 2010, 34(2):113-119.
  • [22]Moss R, McCaw JM, McVernon J: Diagnosis and Antiviral Intervention Strategies for Mitigating an Influenza Epidemic. PLoS One 2011, 6:2.
  • [23]Shim E, Chapman GB, Galvani AP: Decision Making with Regard to Antiviral Intervention during an Influenza Pandemic. Medical Decision Making 2010, 30(4):E64-E81.
  • [24]Colizza V, Barrat A, Barthelemy M, Valleron A-J, Vespignani A: Modeling the worldwide spread of pandemic influenza: Baseline case and containment interventions. PLoS Med 2007, 4(1):95-110.
  • [25]Kelso JK, Halder N, Milne GJ: The Impact of Case Diagnosis Coverage and Diagnosis Delays on the Effectiveness of Antiviral Strategies in Mitigating Pandemic Influenza A/H1N1 2009. PLoS One 2010, 5:11.
  • [26]Gani R, Hughes H, Fleming D, Griffin T, Medlock J, Leach S: Potential impact of antiviral drug use during influenza pandemic. Emerg Infect Dis 2005, 11(9):1355-1362.
  • [27]Tuite A, Kwong J, Fisman D, Greer A: Optimal pandemic influenza vaccine allocation strategies for the Canadian population. PLoS One 2010, 5(5):1-11.
  • [28]Fraser C, Riley S, Anderson RM, Ferguson NM: Factors that make an infectious disease outbreak controllable. PNAS 2004, 101(16):6146-6151.
  • [29]Age and Sex Highlight Tables, 2006 Census. http://www12.statcan.ca/census-recensement/2006/dp-pd/hlt/97-551/index.cfm?Lang=E webcite
  • [30]Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, Heijne J, Sadkowska-Todys M, Rosinska M, Edmunds WJ: Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008, 5(3):381-391.
  • [31]Canadian Community Health Survey (CCHS) - Detailed information for 2007 (Cycle 4.1). http://www.statcan.gc.ca/cgi-bin/imdb/p2SV.pl?Function=getSurvey&SurvId=3226&SurvVer=1&SDDS=3226&InstaId=15282&InstaVer=4&lang=en&db=imdb&adm=8&dis=2 webcite
  • [32]Pregnancy outcomes by age group (live births). http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/hlth65b-eng.htm webcite
  • [33]Pregnancy outcomes by age group (total pregnancies). http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/hlth65a-eng.htm webcite
  • [34]Hall IM, Gani R, Hughes HE, Leach S: Real-time epidemic forecasting for pandemic influenza. Epidemiol Infect 2007, 135(3):372-385.
  • [35]Viboud C, Tam T, Fleming D, Handel A, Miller MA, Simonsen L: Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine 2006, 24(44–46):6701-6707.
  • [36]Longini IM, Halloran ME, Nizam A, Yang Y: Containing pandemic influenza with antiviral agents. Am J Epidemiol 2004, 159(7):623-633.
  • [37]Cooper BS, Pitman RJ, Edmunds WJ, Gay NJ: Delaying the international spread of pandemic influenza. PLoS Med 2006, 3(6):845-855.
  • [38]Longini IM, Seaholm SK, Ackerman E, Koopman JS, Monto AS: Simulation studies of influenza epidemics - assessment of parameter- estimation and sensitivity International Journal of Epidemiology. 1984, 13(4):496-501.
  • [39]Chowell G, Ammon CE, Hengartner NW, Hyman JM: Transmission dynamics of the great influenza pandemic of 1918 in Geneva, Switzerland: Assessing the effects of hypothetical interventions. J Theor Biol 2006, 241(2):193-204.
  • [40]Mills CE, Robins JM, Lipsitch M: Transmissibility of 1918 pandemic influenza. Nature 2004, 432(7019):904-906.
  • [41]Tuite A, Fisman D, Kwong J, Greer A: Seasonal vaccine allocation in the Canadian population during a pandemic. PLOS Currents: Influenza; 2009.
  • [42]Fisman D, Savage R, Gubbay J, Achonu C, Akwar H, al e: Older age and a reduced likelihood of, H1N1 virus infection. N Engl J Med 2009, 2009(361):2000-2001.
  • [43]Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M: Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010, 375(9720):1100-1108.
  • [44]Reed C, Katz JM: Serological suerveys for 2009 pandemic influenza A H1N1. Lancet 2010, 375(9720):1062-1063.
  • [45]Tuite AR, Greer AL, Whelan M, Winter A-L, Lee B, Yan P, Wu J, Moghadas S, Buckeridge D, Pourbohloul B, Fisman DN: Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ 2009, 182(2):131-136.
  • [46]Shaman J, Goldstein E, Lipsitch M: Absolute Humidity and Pandemic Versus Epidemic Influenza. Am J Epidemiol 2011, 173(2):127-135.
  • [47]Shaman J, Pitzer VE, Viboud C, Grenfell BT, Lipsitch M: Absolute Humidity and the Seasonal Onset of Influenza in the Continental United States. PLoS Biol 2010, 8:2.
  • [48]Bjornstad ON, Finkenstadt BF, Grenfell BT: Dynamics of measles epidemics: Estimating scaling of transmission rates using a Time series SIR model. Ecol Monogr 2002, 72(2):169-184.
  • [49]Schanzer DL, McGeer A, Morris K: Statistical estimates of respiratory admissions attributable to seasonal and pandemic influenza for Canada. Influenza Other Respi Viruses 2012.
  • [50]Aoki FY, Allen UD, Stiver HG, Evans GA: The use of antiviral drugs for influenza: Guidance for practitioners 2010–2011. http://www.ammi.ca/pdf/UseOfAntiviralDrugs.pdf webcite
  • [51]Wong LP, Sam IC: Behavioral responses to the influenza A(H1N1) outbreak in Malaysia. J Behav Med 2011, 34(1):23-31.
  • [52]Freiman AJ, Montgomery JP, Green JJ, Thomas DL, Kleiner AM, Boulton ML: Did H1N1 Influenza Prevention Messages Reach the Vulnerable Population Along the Mississippi Gulf Coast? J Public Health Manag Pract 2011, 17(1):52-58.
  • [53]Kok G, Jonkers R, Gelissen R, Meertens R, Schaalma H, de Zwart O: Behavioural intentions in response to an influenza pandemic. BMC Publ Health 2010, 10:174. BioMed Central Full Text
  • [54]Lau JTF, Griffiths S, Au DWH, Choi KC: Changes in knowledge, perceptions, preventive behaviours and psychological responses in the pre-community outbreak phase of the H1N1 epidemic. Epidemiol Infect 2011, 139(1):80-90.
  • [55]Setbon M, Le Pape MC, Letroublon C, Caille-Brillet AL, Raude J: The public’s preventive strategies in response to the pandemic influenza A/H1N1 in France: Distribution and determinants. Prev Med 2011, 52(2):178-181.
  • [56]Bish A, Michie S: Demographic and attitudinal determinants of protective behaviours during a pandemic: A review. Br J Health Psychol 2010, 15:797-824.
  • [57]de Zwart O, Veldhuijzen IK, Richardus JH, Brug J: Monitoring of risk perceptions and correlates of precautionary behaviour related to human avian influenza during 2006–2007 in the Netherlands: results of seven consecutive surveys. BMC Infect Dis 2010, 10:114. BioMed Central Full Text
  • [58]Burch J, Paulden M, Conti S, Stock C, Corbett M, Welton NJ, Ades AE, Sutton A, Cooper N, Elliot AJ, Nicholson K, Duffy S, McKenna C, Stewart L, Westwood M, Palmer S: Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation. Health Technol Assess 2009, 13:58.
  • [59]Zarychanski R, Stuart TL, Kumar A, Doucette S, Elliott L, Kettner J, Plummer F: Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. Can Med Assoc J 2010, 182(3):257.
  • [60]Cavalcante RD, Jorge AMZ, Fortaleza C: Predictors of adherence to influenza vaccination for healthcare workers from a teaching hospital: a study in the prepandemic era. Revista Da Sociedade Brasileira De Medicina Tropical 2010, 43(6):611-614.
  • [61]Goldstein AO, Kincade JE, Gamble G, Bearman RS: Policies and practices for improving influenza immunization rates among healthcare workers. Infect Control Hosp Epidemiol 2004, 25(11):908-911.
  • [62]Oxford JS: Antivirals for the treatment and prevention of epidemic and pandemic influenza. Influenza Other Respi Viruses 2007, 1(1):27-34.
  文献评价指标  
  下载次数:6次 浏览次数:6次